Sign up to save your podcasts
Or
Share ChromaCode Raises $28M in Series C Funding
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ChromaCode Raises $28M in Series C Funding
ChromaCode, Inc., a Carlsbad, Calif.-based molecular diagnostics company, secured $28m in Series C financing.
The round was led by Northpond Ventures with participation from new investors Windham Ventures, Moore Venture Partners and the California Institute of Technology, and existing investors New Enterprise Associates (NEA), Domain Associates and Okapi Ventures.
In conjunction with the funding, Pat Smerkers of Northpond has joined the Board of Directors.
Led by Chief Executive Officer Greg Gosch, ChromaCode leverages High-Definition Polymerase Chain Reaction (HDPCR™) software and reagent technology that uses digital signal processing to improve clinical molecular analysis.
The company’s core of data scientists and molecular biologists leverage patented mathematical methods and algorithms to extract new information from biochemistry reactions to increase the performance capabilities of molecular diagnostics platforms at a very low cost. | To read full story, visit https://startuparound.com/read/1576591210.794224/ChromaCode-Raises-$28M-in-Series-C-Funding?ref=audio_experience
View all episodes
By Startup AroundChromaCode, Inc., a Carlsbad, Calif.-based molecular diagnostics company, secured $28m in Series C financing.
The round was led by Northpond Ventures with participation from new investors Windham Ventures, Moore Venture Partners and the California Institute of Technology, and existing investors New Enterprise Associates (NEA), Domain Associates and Okapi Ventures.
In conjunction with the funding, Pat Smerkers of Northpond has joined the Board of Directors.
Led by Chief Executive Officer Greg Gosch, ChromaCode leverages High-Definition Polymerase Chain Reaction (HDPCR™) software and reagent technology that uses digital signal processing to improve clinical molecular analysis.
The company’s core of data scientists and molecular biologists leverage patented mathematical methods and algorithms to extract new information from biochemistry reactions to increase the performance capabilities of molecular diagnostics platforms at a very low cost. | To read full story, visit https://startuparound.com/read/1576591210.794224/ChromaCode-Raises-$28M-in-Series-C-Funding?ref=audio_experience